MKI67 and B-cell chronic lymphocytic leukemia: This analysis is consistent with previously shown extinction of the proliferation marker Ki67 in CLL cells from patients on ibrutinib26, and a marked reduction in cell size by flow cytometry (Supplementary Fig. 4d, e).